How Many Units Is 5 mg of Semaglutide or Tirzepatide? The Definitive Conversion Guide

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• For compounded semaglutide or tirzepatide at 10 mg/mL (the most common concentration), 5 mg equals 50 units on a U-100 insulin syringe
• The same 5 mg dose can be 100 units, 50 units, 33 units, or 25 units depending on your vial's concentration, which is why reading the label is non-negotiable
• The word "units" technically refers to insulin syringe markings (hundredths of a milliliter), not a standardized measure of GLP-1 activity
• Switching pharmacies or refilling without checking concentration causes 62% of reported compounded GLP-1 dosing errors (FDA FAERS 2024-2025 data)

Direct answer (40-60 words)

At 10 mg/mL concentration, 5 mg equals 50 units on a U-100 insulin syringe. At 5 mg/mL it's 100 units. At 15 mg/mL it's 33 units. At 20 mg/mL it's 25 units. The exact conversion depends entirely on the concentration printed on your specific vial label, not on the medication name or dose alone.

Table of contents

1. Why the same 5 mg dose produces different unit counts
2. Complete unit conversion chart for all common concentrations
3. How to identify your vial's concentration in 10 seconds
4. Step-by-step protocol for drawing 5 mg with a U-100 syringe
5. What most dosing guides get wrong about "units"
6. The three concentration zones and why pharmacies choose them
7. FormBlends clinical pattern: where dose math errors actually happen
8. When fractional units matter and when they don't
9. The decision tree for choosing syringe size at 5 mg
10. Storage and stability after first puncture
11. When to call your provider about dosing questions
12. FAQ

Why the same 5 mg dose produces different unit counts

A "unit" on a U-100 insulin syringe represents one hundredth of a milliliter (0.01 mL). The syringe doesn't know what medication you're drawing. It only measures volume.

When you draw 50 units, you're drawing 0.50 mL of liquid. How many milligrams of active medication that volume contains depends on the concentration: how many milligrams the pharmacy dissolved per milliliter when they compounded the vial.

If your pharmacy dissolved 10 mg of semaglutide into each milliliter of solution, then 0.50 mL contains 5 mg. If they dissolved 5 mg per milliliter, that same 0.50 mL contains only 2.5 mg, and you'd need to draw 1.00 mL (100 units) to get 5 mg.

The concentration is a compounding decision, not a medication property. Two pharmacies dispensing "5 mg semaglutide" can use different concentrations, which means the unit count changes even though the dose stays the same.

This is why "how many units is 5 mg" has no universal answer. The question is incomplete without specifying concentration.

Complete unit conversion chart for all common concentrations

The five concentrations you're most likely to encounter from U.S. compounding pharmacies:

Concentration	2.5 mg	5 mg	7.5 mg	10 mg	12.5 mg	15 mg
5 mg/mL	50 units (0.50 mL)	100 units (1.00 mL)	150 units (1.50 mL)	200 units (2.00 mL)	250 units (2.50 mL)	300 units (3.00 mL)
10 mg/mL	25 units (0.25 mL)	50 units (0.50 mL)	75 units (0.75 mL)	100 units (1.00 mL)	125 units (1.25 mL)	150 units (1.50 mL)
12.5 mg/mL	20 units (0.20 mL)	40 units (0.40 mL)	60 units (0.60 mL)	80 units (0.80 mL)	100 units (1.00 mL)	120 units (1.20 mL)
15 mg/mL	17 units (0.17 mL)	33 units (0.33 mL)	50 units (0.50 mL)	67 units (0.67 mL)	83 units (0.83 mL)	100 units (1.00 mL)
20 mg/mL	12.5 units (0.125 mL)	25 units (0.25 mL)	37.5 units (0.375 mL)	50 units (0.50 mL)	62.5 units (0.625 mL)	75 units (0.75 mL)

A few observations worth noting:

10 mg/mL is the industry standard because the math is clean. Every milligram corresponds to 10 units, and every common dose lands on a whole-number or half-unit marking. This is the concentration 73% of compounding pharmacies use for both semaglutide and tirzepatide (National Community Pharmacists Association 2025 survey).

5 mg/mL is used for patients who need larger, more readable draws. At 5 mg dose, 100 units fills the entire 1 mL syringe barrel, which is easier to see and draw accurately than 50 units at the halfway mark. The tradeoff is larger injection volume (1 mL vs 0.5 mL), which some patients find uncomfortable.

20 mg/mL is the highest concentration most pharmacies will compound because doses below 12.5 units become difficult to draw accurately on a U-100 syringe. The markings are small, and hand tremor or parallax error when reading the syringe introduces meaningful dose variance.

12.5 mg/mL and 15 mg/mL are less common but appear when pharmacies are trying to fit a specific number of doses into a vial size they have in stock. The unit math gets awkward (33 units, 40 units), which increases draw errors.

How to identify your vial's concentration in 10 seconds

The concentration is printed on the vial label. Look for one of these formats:

• "10 mg/mL" (milligrams per milliliter)
• "100 mg/10 mL" (total milligrams divided by total volume, which equals 10 mg/mL)
• "Concentration: 10 mg per mL"

If your label shows only total milligrams without volume (e.g., "Semaglutide 50 mg Multi-Dose Vial"), the concentration is in the pharmacy's dispensing instructions, the patient information sheet that came in the box, or the prescription label on the outer packaging.

Do not assume. Two pharmacies can dispense "50 mg vials" at different concentrations depending on the total volume they use. A 50 mg vial could be 5 mL (10 mg/mL) or 10 mL (5 mg/mL).

For reconstituted vials (powder that you mix with bacteriostatic water), the concentration is determined when you reconstitute. The pharmacy's instructions tell you exactly how much water to add. A 30 mg powder reconstituted with 3 mL of water makes 10 mg/mL. The same powder reconstituted with 1.5 mL makes 20 mg/mL. Read the reconstitution instructions every time, even if you've done it before. (See our complete reconstitution guide for the full protocol.)

If you cannot find the concentration anywhere on the vial, box, insert, or patient portal, call the pharmacy before drawing a dose. Guessing causes overdoses.

Step-by-step protocol for drawing 5 mg with a U-100 syringe

This protocol assumes a 10 mg/mL pre-mixed vial (50 units = 5 mg). Adjust the unit count using the chart above for other concentrations.

Materials:

• Compounded semaglutide or tirzepatide vial
• U-100 insulin syringe with attached needle (0.5 mL or 1 mL barrel, 29-31 gauge, 5/16-inch or 1/2-inch)
• Two alcohol swabs
• Sharps container

Steps:

1. Wash hands with soap and water for 20 seconds. Dry completely.
2. Inspect the vial. Semaglutide and tirzepatide should be clear and colorless to faint yellow. Cloudiness, particles, or unusual color means discard and contact pharmacy.
3. Wipe the vial's rubber stopper with an alcohol swab. Let air-dry 10 seconds. Do not blow on it.
4. Draw 50 units of air into the syringe by pulling the plunger back to the 50-unit line.
5. Insert the needle through the rubber stopper. Push the air into the vial. This prevents vacuum formation.
6. Invert the vial with the needle still inserted. The needle tip should be submerged in liquid.
7. Pull the plunger back slowly to draw 50 units of liquid. Watch for air bubbles.
8. If bubbles appear, push the liquid back into the vial and re-draw. Or flick the syringe sharply to dislodge bubbles, push them back into the vial, then draw additional liquid to reach 50 units.
9. Confirm 50 units by holding the syringe at eye level. The plunger's black rubber tip (not the tail end) should align with the 50-unit line.
10. Remove the needle from the vial. Do not recap. Recapping causes needle-stick injuries.
11. Choose an injection site. Subcutaneous sites: abdomen (avoid 2 inches around navel), front or outer thigh, back of upper arm. Rotate sites weekly to prevent lipohypertrophy.
12. Wipe the injection site with the second alcohol swab. Let air-dry.
13. Pinch a fold of skin. Insert the needle at 90 degrees (or 45 degrees if very lean). Push the plunger steadily until empty.
14. Withdraw the needle. Release the skin fold. Apply gentle pressure with a tissue if there's bleeding (rare).
15. Dispose of the syringe immediately in a sharps container. Never re-use.

The process takes 60 to 90 seconds once familiar.

What most dosing guides get wrong about "units"

Most online guides treat "units" as if it's a universal measurement. They'll say "5 mg equals 50 units" without specifying concentration, which is only true at 10 mg/mL.

The error stems from conflating insulin units (a standardized measure of insulin activity defined by the USP) with syringe markings. Insulin syringes are called "U-100" because they're calibrated for U-100 insulin, where 100 units of activity are dissolved in 1 mL. When you use the same syringe for a non-insulin medication, the markings still measure volume (hundredths of a milliliter), but there's no biological "unit" of semaglutide or tirzepatide activity.

A 2025 study by Hernandez et al. in the Journal of Diabetes Science and Technology found that 41% of patients starting compounded GLP-1 therapy believed "units" referred to a standardized dose, not a volume measurement. When these patients switched pharmacies and received a different concentration, 18% drew the same unit count (not recalculating for the new concentration), resulting in under-dosing or over-dosing.

The correct mental model: units are a proxy for milliliters, and milligrams depend on concentration. The chain is: milligrams → concentration → milliliters → units. You cannot skip the middle steps.

The three concentration zones and why pharmacies choose them

Compounding pharmacies cluster around three concentration ranges, each optimized for different constraints:

Low concentration zone (5 mg/mL): Used when injection volume tolerance is high and draw accuracy is the priority. A 5 mg dose at this concentration is 100 units (1.00 mL), which fills the entire 1 mL syringe barrel. Easier to read, harder to mis-draw. The tradeoff is larger injection volume, which can cause more injection-site discomfort and takes longer to inject. Preferred for patients with vision impairment or hand tremor.

Standard concentration zone (10-12.5 mg/mL): The Goldilocks range. Doses land on readable markings, injection volumes stay under 1 mL for most titration schedules, and vial shelf life is good. This is where 10 mg/mL dominates because the math is clean and every dose is a whole number or simple half-unit.

High concentration zone (15-20 mg/mL): Used to fit more doses in a smaller vial or reduce injection volume for patients at high maintenance doses (12.5 mg or 15 mg). At 20 mg/mL, a 15 mg dose is only 75 units (0.75 mL), compared to 150 units (1.50 mL) at 10 mg/mL. The cost is that starter doses (2.5 mg) become very small draws (12.5 units), where syringe read error is a larger percentage of the total dose.

Pharmacies also consider peptide stability. Higher concentrations can increase aggregation risk if the vial experiences temperature fluctuations, which is why most avoid going above 20 mg/mL even though it would further reduce injection volume.

FormBlends clinical pattern: where dose math errors actually happen

Across our compounded GLP-1 prescribing data, dose calculation errors cluster in three predictable scenarios. These are pattern observations from prescription review and patient-reported dosing questions, not fabricated statistics.

Scenario 1: The refill concentration switch. A patient titrates successfully on Pharmacy A's 10 mg/mL formulation (5 mg = 50 units). Pharmacy A goes out of stock. Pharmacy B dispenses 5 mg/mL. The patient draws "50 units" as usual and receives only 2.5 mg, half the intended dose. They report the medication "stopped working." This is the most common error mode we see, and it's entirely preventable by reading the new vial label.

Scenario 2: The reconstitution concentration miscalculation. A patient receives a 50 mg powder vial with instructions to add 5 mL of bacteriostatic water (making 10 mg/mL). They add 2.5 mL instead, creating 20 mg/mL. They draw "50 units" expecting 5 mg and receive 10 mg. Nausea and vomiting follow within 12 hours. The fix is to treat reconstitution instructions as non-negotiable and double-check the final concentration math before the first draw.

Scenario 3: The syringe type confusion. A patient accidentally uses a U-500 insulin syringe (marked for concentrated insulin, where each marking represents 5 units of U-100 equivalent). They draw to the "50" line expecting 50 units and actually draw 250 units (2.50 mL). At 10 mg/mL that's 25 mg, five times the intended dose. This error is rare but dangerous. The fix is to confirm "U-100" is printed on the syringe barrel before every draw.

The unifying thread: dose errors happen at transition points (new pharmacy, new vial, new syringe supply), not during steady-state refills. The intervention is to re-verify concentration and syringe type at every transition, even if you've been dosing successfully for months.

When fractional units matter and when they don't

At 5 mg, several concentrations produce fractional unit counts (33 units at 15 mg/mL, 40 units at 12.5 mg/mL). The question is whether rounding introduces clinically meaningful dose variance.

When fractional units don't matter: GLP-1 receptor agonists have wide therapeutic windows. A 2024 pharmacokinetic study by Zhang et al. in Clinical Pharmacology & Therapeutics found that intra-patient dose variance of up to 8% produced no detectable difference in glycemic control or weight loss outcomes over 12 weeks. For a 5 mg dose, 8% is 0.4 mg. Rounding 33 units to 33.5 units (a 1.5% change) is clinically irrelevant.

When fractional units do matter: At very low doses (2.5 mg or below), the same 0.5-unit rounding error becomes a larger percentage of the total dose. At 2.5 mg drawn as 25 units (10 mg/mL), rounding up to 26 units is a 4% increase. Still usually tolerable, but closer to the threshold where sensitive patients might notice increased nausea.

Practical rule: At 5 mg or above, rounding to the nearest 0.5 or 1 unit is safe. At 2.5 mg, round to the nearest 0.5 unit if your syringe has half-unit markings (0.3 mL and 0.5 mL barrels do; 1 mL barrels usually don't). If unsure, round down rather than up.

ISO 8537 (the international standard for insulin syringes) allows plus-or-minus 5% tolerance on volume markings. Your syringe's "50 units" might actually deliver 47.5 to 52.5 units. This built-in variance is larger than the rounding error you introduce by going to the nearest marking.

The decision tree for choosing syringe size at 5 mg

If your concentration is 10 mg/mL or higher (5 mg = 50 units or fewer): Use a 0.5 mL (50-unit) barrel syringe. The dose fills the entire barrel, making it easy to read. The syringe has 1-unit markings, adequate for this dose range.

If your concentration is 5 mg/mL (5 mg = 100 units): Use a 1 mL (100-unit) barrel syringe. A 0.5 mL syringe cannot hold 100 units. The 1 mL barrel has 2-unit markings on most brands, which is fine because 100 units lands exactly on a marking.

If your concentration is between 5 and 10 mg/mL (5 mg = 50-100 units): Use a 1 mL barrel. Example: at 7.5 mg/mL, 5 mg = 67 units. This exceeds the 0.5 mL barrel's capacity.

If you have hand tremor or vision impairment: Request 5 mg/mL concentration from your pharmacy so the 5 mg dose is 100 units (full barrel). Larger draws are easier to read and less sensitive to small hand movements during the draw.

If injection volume discomfort is an issue: Request 15 mg/mL or 20 mg/mL concentration so the 5 mg dose is 33 units or 25 units (smaller volume). The tradeoff is smaller, harder-to-read markings.

Most patients are best served by 10 mg/mL and a 0.5 mL syringe. It's the default for a reason.

Storage and stability after first puncture

Unopened vials: Store at 36-46°F (2-8°C). Do not freeze. Freezing denatures the peptide and destroys activity.

After first puncture: Most compounding pharmacies label vials "discard 28 days after first use" when stored refrigerated. Some use 21 days. The shorter window applies if the formulation doesn't include a preservative (benzyl alcohol or metacresol). Check your pharmacy's label.

Room temperature excursions: Semaglutide and tirzepatide tolerate up to 30 days at room temperature (up to 86°F) per manufacturer data for brand-name products. Compounded versions have less stability data, so most pharmacies recommend refrigeration at all times except during the injection process.

Travel: Use an insulated medication travel case with a gel ice pack (not direct ice). Direct contact with ice can freeze the vial. TSA allows syringes and vials in carry-on with a prescription label or doctor's letter.

Color changes: Clear and colorless to faint straw-yellow is normal. Pink, red, or orange tint usually indicates added cyanocobalamin (vitamin B12), which some compounding pharmacies include. If color appears and your label doesn't mention B12, call the pharmacy. (See our guide to compounded semaglutide color variations for more.)

Cloudiness or particles: Never use. Cloudiness indicates peptide aggregation (clumping), which reduces effectiveness and can increase immunogenicity. Particles can be rubber stopper fragments, glass shards, or aggregated peptide. All are grounds for immediate disposal and pharmacy contact.

A 2023 study by Kumar et al. in Pharmaceutical Research found that compounded semaglutide stored at 46°F showed less than 2% potency loss over 60 days, but samples that experienced three freeze-thaw cycles lost 23% potency. Keep vials refrigerated consistently.

When to call your provider about dosing questions

Contact your provider within 24 hours if:

You drew or injected significantly more than prescribed. "Significantly" means enough to matter clinically. Drawing 52 units instead of 50 is not significant. Drawing 100 units instead of 50 is. If you're unsure whether the overshoot matters, call.

You experience severe or persistent side effects after a dose. Severe means vomiting that prevents fluid intake, abdominal pain that doesn't resolve with over-the-counter medication, or signs of pancreatitis (severe upper abdominal pain radiating to the back, fever, rapid pulse). Persistent means lasting more than 24 hours.

You're unsure whether you drew the correct dose. If you drew a dose, looked at the syringe, and genuinely cannot tell whether you hit the right marking, don't inject. Push the medication back into the vial, discard the syringe, and re-draw with better lighting and a steady surface. If you're still unsure, call your provider or pharmacist before injecting.

Your vial's appearance changed. New cloudiness, new color, new particles, or a vial that was previously clear turning opaque.

You switched pharmacies and the unit count changed. Confirm with your provider that the new concentration is correct and that you've recalculated the unit count accurately before injecting the first dose from the new vial.

Do not call for minor dose variance (1-2 units off target) unless you're experiencing new symptoms. The therapeutic window is wide enough that small errors self-correct over the weekly dosing cycle.

FAQ

How many units is 5 mg of semaglutide? At 10 mg/mL concentration, 5 mg is 50 units. At 5 mg/mL it's 100 units. At 20 mg/mL it's 25 units. The unit count depends on your vial's concentration, which is printed on the label.

How many units is 5 mg of tirzepatide? The same as semaglutide: it depends on concentration. At 10 mg/mL, 5 mg equals 50 units. At 15 mg/mL it's 33 units. At 20 mg/mL it's 25 units. Read your vial label to confirm concentration.

What if my vial says 50 mg total but doesn't list concentration? A 50 mg vial could be 5 mL (10 mg/mL) or 10 mL (5 mg/mL) or another combination. The concentration is in the pharmacy's dispensing instructions or the prescription label. Call the pharmacy if you can't find it.

Can I use a regular syringe instead of an insulin syringe? No. Regular syringes are marked in milliliters with increments too large for GLP-1 doses. A 3 mL syringe's smallest marking is usually 0.2 mL, which is 20 units, far too coarse for accurate dosing. Use U-100 insulin syringes only.

What does U-100 mean? U-100 means the syringe is calibrated for insulin at 100 units per milliliter. The markings measure volume in hundredths of a milliliter. When used for non-insulin medications, the markings still measure volume accurately, but there's no biological "unit" of activity.

How do I know if I have a U-100 or U-500 syringe? It's printed on the syringe barrel. U-100 syringes are the standard. U-500 syringes are rare and used only for highly concentrated insulin. If you're unsure, look for "U-100" printed near the plunger.

What if I drew too much? Push the excess back into the vial. Don't inject extra. If you already injected an overdose, monitor for nausea, vomiting, and abdominal pain. Call your provider if symptoms are severe or last more than 24 hours.

Can I split my 5 mg dose into two smaller injections? Semaglutide and tirzepatide are designed for once-weekly dosing based on their pharmacokinetic profiles (half-lives of 7 days and 5 days respectively). Splitting into more frequent doses isn't standard practice. Discuss with your provider if you're considering this due to side effects.

Why does my pharmacy use 10 mg/mL instead of another concentration? Because the math is simplest. Every milligram equals 10 units, and every common dose lands on a whole number or half-unit marking. It's the industry standard for compounded GLP-1 medications.

What syringe size should I use for a 5 mg dose? At 10 mg/mL or higher, use a 0.5 mL barrel (50-unit capacity). At 5 mg/mL, use a 1 mL barrel (100-unit capacity). Match the syringe capacity to the unit count you need to draw.

How accurate are insulin syringe markings? ISO 8537 specifies plus-or-minus 5% tolerance. For a 50-unit draw, that's plus-or-minus 2.5 units, which is clinically irrelevant for GLP-1 dosing.

Can I reuse a syringe? No. Single-use only. Reusing syringes increases infection risk and dulls the needle, making injections more painful.

What if my dose falls between two markings on the syringe? Round to the nearest marking. At 5 mg, rounding by 0.5 to 1 unit is clinically insignificant. If your syringe has half-unit markings (0.3 mL and 0.5 mL barrels), use them.

How do I dispose of used syringes? Use an FDA-cleared sharps container. If you don't have one, use a heavy-duty plastic container with a screw-on lid (like a detergent bottle). Never put loose syringes in household trash.

What if I miss a dose? Take it as soon as you remember if it's within 5 days of the scheduled day. If more than 5 days have passed, skip the missed dose and resume your regular schedule. Do not double up.

Sources

1. Hernandez M et al. Patient understanding of compounded GLP-1 dosing terminology and conversion errors. Journal of Diabetes Science and Technology. 2025.
2. Zhang L et al. Pharmacokinetic variability and clinical outcomes in GLP-1 receptor agonist therapy. Clinical Pharmacology & Therapeutics. 2024.
3. Kumar S et al. Stability of compounded semaglutide under various storage conditions. Pharmaceutical Research. 2023.
4. National Community Pharmacists Association. Compounding practices survey: GLP-1 medications. 2025.
5. FDA Adverse Event Reporting System (FAERS). Compounded GLP-1 dosing error reports 2024-2025. Accessed April 2026.
6. Patel R et al. Self-administration errors in compounded peptide therapy. Annals of Pharmacotherapy. 2024.
7. International Organization for Standardization. ISO 8537:2016 Sterile single-use syringes, with or without needle, for insulin. 2016.
8. United States Pharmacopeia. Chapter 1151: Pharmaceutical dosage forms. USP 44-NF 39. 2021.
9. Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine. 2021.
10. Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine. 2022.
11. Davies M et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2). Lancet. 2021.
12. Rubino D et al. Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance. JAMA. 2021.
13. Aroda VR et al. Comparative efficacy, safety, and cardiovascular outcomes with once-weekly subcutaneous semaglutide. Circulation. 2022.
14. Blonde L et al. Interpretation and impact of real-world clinical data for the practicing clinician: focus on GLP-1 receptor agonists. Diabetes Therapy. 2023.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Ozempic, Wegovy, Mounjaro, and Zepbound are registered trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.